Broad-spectrum antiviral activity of virazole: 1-β-D-ribofuranosyl-1, 2,4-triazole-3-carboxamide

Science

Volumn 177, Issue 4050, 1972, Pages 705-706

  Sidwell, Robert W ^a   Huffman, John H ^a   Khare, G P ^a   Allen, Lois B ^a   Witkowski, J T ^a   Robins, Roland K ^a  

^a Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIVIRUS AGENT; NUCLEOSIDE; RIBONUCLEOSIDE; TRIAZOLE DERIVATIVE;

ADENOVIRUS; ANIMAL; ARTICLE; CELL CULTURE; CYTOMEGALOVIRUS; DNA VIRUS; DRUG EFFECT; FRIEND LEUKEMIA VIRUS; MICROBIOLOGICAL EXAMINATION; MOUSE; ORTHOMYXOVIRUS; PARAMYXOVIRUS; POLIOMYELITIS VIRUS; RABBIT; RABIES VIRUS; RHINOVIRUS; RNA VIRUS; SEMLIKI FOREST ALPHAVIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ADENOVIRIDAE; AMIDES; ANIMAL; ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA VIRUSES; FRIEND MURINE LEUKEMIA VIRUS; MICE; MICROBIAL SENSITIVITY TESTS; NUCLEOSIDES; ORTHOMYXOVIRIDAE; POLIOVIRUSES; RABBITS; RABIES VIRUS; RESPIROVIRUS; RHINOVIRUS; RIBONUCLEOSIDES; RNA VIRUSES; SEMLIKI FOREST VIRUS; TRIAZOLES; VACCINIA VIRUS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS DISEASES;

EID: 0015523596     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.177.4050.705     Document Type: Article

References (0)